Display options
Cite
Gerber JM. Isolated clonal cytogenetic abnormalities after high-dose therapy: do they matter?. Biol Blood Marrow Transplant. 2014;20(8):1077-8doi: 10.1016/j.bbmt.2014.06.021.
Gerber, J. M. (2014). Isolated clonal cytogenetic abnormalities after high-dose therapy: do they matter?. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 20(8), 1077-8. https://doi.org/10.1016/j.bbmt.2014.06.021
Gerber, Jonathan M. "Isolated clonal cytogenetic abnormalities after high-dose therapy: do they matter?." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 20,8 (2014): 1077-8. doi: https://doi.org/10.1016/j.bbmt.2014.06.021
Gerber JM. Isolated clonal cytogenetic abnormalities after high-dose therapy: do they matter?. Biol Blood Marrow Transplant. 2014 Aug;20(8):1077-8. doi: 10.1016/j.bbmt.2014.06.021. Epub 2014 Jun 20. PMID: 24953018.
Copy Download .nbib Format: NLM
Share it on

Biol Blood Marrow Transplant. 2014 Aug;20(8):1077-8. doi: 10.1016/j.bbmt.2014.06.021. Epub 2014 Jun 20.

Isolated clonal cytogenetic abnormalities after high-dose therapy: do they matter?.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Jonathan M Gerber

Affiliations

  1. Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina. Electronic address: [email protected].

PMID: 24953018 DOI: 10.1016/j.bbmt.2014.06.021

[No abstract available.]

MeSH terms

Publication Types